CN116687999A - Preparation method of selfheal oral liquid - Google Patents
Preparation method of selfheal oral liquid Download PDFInfo
- Publication number
- CN116687999A CN116687999A CN202310732445.8A CN202310732445A CN116687999A CN 116687999 A CN116687999 A CN 116687999A CN 202310732445 A CN202310732445 A CN 202310732445A CN 116687999 A CN116687999 A CN 116687999A
- Authority
- CN
- China
- Prior art keywords
- fermentation
- extraction
- selfheal
- materials
- oral liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 43
- 235000008113 selfheal Nutrition 0.000 title claims abstract description 32
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 244000299788 selfheal Species 0.000 title 1
- 238000000855 fermentation Methods 0.000 claims abstract description 61
- 230000004151 fermentation Effects 0.000 claims abstract description 61
- 244000179560 Prunella vulgaris Species 0.000 claims abstract description 42
- 238000000605 extraction Methods 0.000 claims abstract description 41
- 238000000194 supercritical-fluid extraction Methods 0.000 claims abstract description 9
- 239000000463 material Substances 0.000 claims description 56
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 38
- 238000003756 stirring Methods 0.000 claims description 28
- 150000001875 compounds Chemical class 0.000 claims description 21
- 239000000706 filtrate Substances 0.000 claims description 20
- 238000001914 filtration Methods 0.000 claims description 19
- 239000000284 extract Substances 0.000 claims description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 15
- 229960003237 betaine Drugs 0.000 claims description 15
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 14
- 239000008367 deionised water Substances 0.000 claims description 14
- 229910021641 deionized water Inorganic materials 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 14
- 125000002947 alkylene group Chemical group 0.000 claims description 13
- 238000002156 mixing Methods 0.000 claims description 13
- 230000001954 sterilising effect Effects 0.000 claims description 13
- 125000002252 acyl group Chemical group 0.000 claims description 12
- -1 trityl fluorosilane Chemical compound 0.000 claims description 12
- 230000001580 bacterial effect Effects 0.000 claims description 11
- 229910052799 carbon Inorganic materials 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 10
- 238000007873 sieving Methods 0.000 claims description 10
- 238000004140 cleaning Methods 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 8
- 241000194108 Bacillus licheniformis Species 0.000 claims description 7
- 244000063299 Bacillus subtilis Species 0.000 claims description 7
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 7
- 241000123069 Ocyurus chrysurus Species 0.000 claims description 7
- 241000235342 Saccharomycetes Species 0.000 claims description 7
- 240000008042 Zea mays Species 0.000 claims description 7
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 7
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 7
- 235000005822 corn Nutrition 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 238000004821 distillation Methods 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 241000186660 Lactobacillus Species 0.000 claims description 2
- 235000013312 flour Nutrition 0.000 claims description 2
- 229940039696 lactobacillus Drugs 0.000 claims description 2
- 238000000643 oven drying Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 8
- 239000002699 waste material Substances 0.000 abstract description 2
- 230000000857 drug effect Effects 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 16
- 241000894006 Bacteria Species 0.000 description 15
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 10
- 235000010674 Prunella vulgaris Nutrition 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 6
- 229930003935 flavonoid Natural products 0.000 description 6
- 150000002215 flavonoids Chemical class 0.000 description 6
- 235000017173 flavonoids Nutrition 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 6
- 239000004299 sodium benzoate Substances 0.000 description 6
- 235000010234 sodium benzoate Nutrition 0.000 description 6
- 229940013618 stevioside Drugs 0.000 description 6
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 6
- 235000019202 steviosides Nutrition 0.000 description 6
- 239000004310 lactic acid Substances 0.000 description 5
- 235000014655 lactic acid Nutrition 0.000 description 5
- 235000012054 meals Nutrition 0.000 description 5
- 150000003648 triterpenes Chemical class 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 150000002989 phenols Chemical class 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 150000003797 alkaloid derivatives Chemical class 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 229910002091 carbon monoxide Inorganic materials 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- 101000800130 Bos taurus Thyroglobulin Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 241000721692 Lythrum Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 108010034949 Thyroglobulin Proteins 0.000 description 1
- 102000009843 Thyroglobulin Human genes 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000005272 common selfheal Nutrition 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000011206 morphological examination Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960002175 thyroglobulin Drugs 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- B01D11/0203—Solvent extraction of solids with a supercritical fluid
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- B01D11/0288—Applications, solvents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/54—Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Diabetes (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a preparation method of selfheal oral liquid. Carrying out supercritical extraction on the effective components in the selfheal by using the compounded entrainer; the drug effect of the selfheal is further improved through combined fermentation. The first aim of the invention is to promote the extraction of the effective components of the selfheal, thereby reducing the waste. The second purpose of the invention is to provide a preparation method of the selfheal oral liquid with better curative effect.
Description
Technical Field
The invention relates to the field of preparations, in particular to a preparation method of selfheal oral liquid.
Background
Spica Prunellae is a common medicinal plant belonging to Labiatae, prunella, under the academic name Prunella vulgaris L, also called Spica Prunellae, lythrum, etc. It is grown on road side, field, hillside and other places and distributed in most areas of China. Prunella vulgaris is annual or biennial herbaceous plant, and its stem is upright or inclined, and its height is generally 15-60 cm. The leaves are contra-living, usually in the shape of oval or oval lanceolate needles, with fine serrations on the edges. The inflorescences are purple or blue-purple cone inflorescences, and the flowers are small and dense. The whole plant has rich grass fragrance. The main chemical components of the selfheal include flavonoids, tannins, volatile oil, organic acid and the like. Wherein the flavonoids are one of the important effective components of the selfheal, and have various pharmacological effects. Prunella vulgaris also contains various amino acids and minerals such as glutamic acid, serine, calcium, iron, zinc, etc.
Prunella vulgaris is regarded as a precious traditional Chinese medicine for treating various diseases in traditional Chinese medicine, and the root, stem, leaf, flower and other parts of the Prunella vulgaris can be used as medicines. Modern medical research shows that selfheal has broad-spectrum bioactivity and can be used for treating cold, hepatitis, hypertension, diabetes and other diseases.
The common selfheal fruit-spike oral liquid is taken as an oral liquid preparation convenient to drink, and the retention of the effective components is always a problem worthy of research. In addition, how to improve the curative effect of the selfheal oral liquid preparation is a hot spot of current research.
Disclosure of Invention
The invention aims to solve the technical problems that:
the first aim of the invention is to promote the extraction of the effective components of the selfheal, thereby reducing the waste.
The second purpose of the invention is to provide a preparation method of the selfheal oral liquid with better curative effect.
In order to solve the technical problems, the technical scheme adopted by the invention comprises the following steps:
the method comprises the following specific steps of:
1) Pretreatment:
cleaning Prunellae Spica, oven drying at 50-60deg.C to constant weight, pulverizing, and sieving with 60 mesh sieve to obtain Prunellae Spica powder;
2) Supercritical extraction:
extracting the selfheal powder in a supercritical extraction device, adding entrainer into an entrainer tank, setting the extraction pressure to be 16-18Mpa, the extraction temperature to be 28-30 ℃, the CO2 flow to be 20-25L/h, and the extraction time to be 1-1.5h, and collecting the rest materials and the mixed extract respectively after the extraction is completed;
3) Separating:
placing the above mixed extract in a reduced pressure distillation device, setting pressure at 15mmHg and temperature at 70deg.C, and separating effective substances from Prunellae Spica to obtain pure extractive solution;
wherein, entrainer is: adding 1.2-1.6 parts of N-long-chain acyl alkylene betaine and 1 part of trityl fluorosilane into 4-6 parts of 70% ethanol solution, stirring and dispersing at 400r/min for 10 min.
The method comprises the following specific steps of fermenting the extracted residual materials:
a. washing the residual materials collected after extraction with deionized water for 4-6 times, draining off water, and drying at 50-60 ℃ until the weight is constant to obtain a dry material;
b. respectively taking bare stems Jin Yaozi and madder which have the same weight as the dried materials, uniformly mixing the bare stems Jin Yaozi and the madder with the dried materials, crushing the mixture, and sieving the crushed mixture with a 60-mesh sieve to obtain a fermented material;
c. adding the fermentation materials into a fermentation tank, adding a compound bacterial liquid accounting for 1-3% of the mass of the fermentation materials, adding corn flour accounting for 5-6% of the mass of the fermentation materials as a carbon source, finally adding deionized water with the mass-volume ratio of 2:1 to the fermentation materials, stirring uniformly, starting fermentation, fermenting for 3-5 days, and filtering and sterilizing to obtain a fermentation filtrate;
the preparation method of the compound bacterial liquid comprises the following steps: adding 2 parts of bacillus subtilis, 1 part of bacillus licheniformis, 1 part of lactobacillus and 1 part of saccharomycete into 5 parts of 10% brown sugar water, uniformly stirring, and standing for 12 hours at the temperature of 32-36 ℃ to obtain the compound bacterial liquid.
Wherein the pure extract obtained by extraction and the fermented filtrate obtained by fermentation are mixed to prepare the oral liquid preparation acceptable by medicine.
The invention is characterized in that:
1) Supercritical extraction is an effective low-temperature extraction means and relies on specific entrainers to enhance extraction efficiency. The principle of the entrainer is that the entrainer can influence the solubility and selectivity of solute in supercritical fluid, in order to improve the content of flavonoids and phenolic substances in the extract, N-long-chain acyl alkylene betaine and trityl fluorosilane are compounded as the entrainer, in the extraction process of the effective components of the traditional Chinese medicine, alkaloid can be used as an extraction solvent, mainly for the purpose that the alkaloid is purely natural and relatively safe to extract, but the conventional alkaloid has good extraction effect on flavonoids and is not obvious in extraction effect on phenols and triterpenes, the N-long-chain acyl alkylene betaine is selected, alkylene on N-long-chain acyl alkylene betaine molecules can enhance the wettability of molecules, so that the N-long-chain acyl betaine can better disperse, the polarity of the molecules can be enhanced, and the long-chain betaine has better wettability and emulsifying property compared with the short-chain betaine, so that the extraction effect on various effective components in the selfheal can be enhanced; the trityl fluorosilane is used as a surfactant, is more stable than the conventional surfactant, can regulate the polarity of carbon dioxide, is beneficial to the formation of supercritical fluid microemulsion, is beneficial to the increase of the permeability of cell membranes, is beneficial to the release of flavonoids, phenols and triterpenes, contains three benzyl groups in the trityl fluorosilane molecule, can play a role in protecting other functional groups, and can prevent other functional groups from participating in unwanted reactions, and the N-long-chain acyl alkylene betaine and the trityl fluorosilane are used together as entrainers to have a synergistic effect.
2) The invention uses the bare stem Jin Yaozi and the madder to carry out combined fermentation, and the fermented raw materials can promote the repair of abnormal activation of the pi3k/akt channel by the selfheal oral liquid, so that the proliferation and the apoptosis of cells are balanced, and the efficacy of resolving hard mass and detumescence is improved. In addition, the naked stem golden kidney has various pharmacological effects of resisting oxidation, reducing blood pressure, resisting tumor, regulating immunity and the like, and has certain auxiliary effects on preventing and treating cardiovascular and cerebrovascular diseases, hepatitis, tumor and other diseases. The bare stem Jin Yaozi and the selfheal can be fermented in a combined way, so that the bitter taste of the selfheal can be improved, the selfheal can be absorbed more easily, and the effects of clearing heat and detoxicating, promoting urination and detumescence, reducing blood pressure and the like are enhanced. Wu Qian as a medicinal material for clearing heat and detoxicating has synergistic effect on Prunellae Spica, and the fermentation of radix Rubiae increases vitamins and amino acids in the fermentation liquid, so that the taste of the medicinal liquid is soft.
Description of the embodiments
The present invention will be described in further detail with reference to examples.
The N-long chain acyl alkylene betaine used in the embodiment of the invention is purchased by Shanghai Chuxing chemical industry Co., ltd, the selfheal is a Jiangxi local medicinal material, and the rest raw materials or chemical reagents are obtained through conventional commercial paths if no special description exists.
Example 1
The embodiment comprises the following steps:
1) Preparing an entrainer:
adding 1.4kg of N-long-chain acyl alkylene betaine and 1kg of trityl fluorosilane into 5L of 70% ethanol solution, stirring and dispersing at the speed of 400r/min for 10min to obtain the catalyst;
2) Extraction:
cleaning 800g of selfheal, drying at 55 ℃ to constant weight, crushing and sieving with a 60-mesh sieve to obtain selfheal powder; extracting the Prunella vulgaris powder in supercritical extraction device, adding 400ml entrainer into entrainer tank, setting extraction pressure to 17Mpa, and extracting at 29 deg.C, and CO 2 The flow is 23L/h, the extraction time is 1.3h, and the residual materials and the mixed extract are respectively collected after the extraction is completed; placing the above mixed extract in a reduced pressure distillation device, setting pressure at 15mmHg and temperature at 70deg.C, and separating effective substances from Prunellae Spica to obtain pure extractive solution;
example 2
The embodiment comprises the following steps:
1) Preparing an entrainer:
adding 1.2kg of N-long-chain acyl alkylene betaine and 1kg of trityl fluorosilane into 4L of 70% ethanol solution, stirring and dispersing at the speed of 400r/min for 10min to obtain the catalyst;
3) Extraction:
cleaning 800g of selfheal, drying at 50 ℃ to constant weight, crushing and sieving with a 60-mesh sieve to obtain selfheal powder; extracting the Prunella vulgaris powder in supercritical extraction device, adding 300ml entrainer into entrainer tank, setting extraction pressure to 16Mpa, and extracting at 28deg.C, CO 2 The flow is 20L/h, the extraction time is 1h, and the residual materials and the mixed extract are respectively collected after the extraction is completed; placing the above mixed extract in a reduced pressure distillation device, setting pressure at 15mmHg and temperature at 70deg.C, and separating effective substances from Prunellae Spica to obtain pure extractive solution;
example 3
The embodiment comprises the following steps:
1) Preparing an entrainer:
adding 1.6kg of N-long-chain acyl alkylene betaine and 1kg of trityl fluorosilane into 6L of 70% ethanol solution, stirring and dispersing at the speed of 400r/min for 10min to obtain the catalyst;
3) Extraction:
cleaning 800g of selfheal, drying at 60 ℃ to constant weight, crushing and sieving with a 60-mesh sieve to obtain selfheal powder; extracting the Prunella vulgaris powder in supercritical extraction device, adding 400ml entrainer into entrainer tank, setting extraction pressure at 18Mpa, and extracting at 30deg.C, and CO 2 The flow is 25L/h, the extraction time is 1.5h, and the residual materials and the mixed extract are respectively collected after the extraction is completed; placing the above mixed extract in a reduced pressure distillation device, setting pressure at 15mmHg and temperature at 70deg.C, and separating effective substances from Prunellae Spica to obtain pure extractive solution;
comparative example 1
The difference between this comparative example and example 1 is that:
1) Preparing an entrainer:
adding 1.4kg of N-long-chain acyl alkylene betaine into 5L of 70% ethanol solution, stirring and dispersing at 400r/min for 10min to obtain the final product;
the procedure is as in example 1.
Comparative example 2
The difference between this comparative example and example 1 is that:
1) Preparing an entrainer:
adding 1kg of trityl fluorosilane into 5L of 70% ethanol solution, stirring and dispersing at the speed of 400r/min for 10min to obtain the preparation;
the procedure is as in example 1.
Comparative example 3
The difference between this comparative example and example 1 is that:
1) Preparing an entrainer:
adding 1kg of N-long-chain acyl alkylene betaine and 1.4kg of trityl fluorosilane into 5L of 70% ethanol solution, stirring and dispersing at the speed of 400r/min for 10min to obtain the preparation;
the procedure is as in example 1.
Experiment 1:
1) Total flavone content: spectrophotometry is adopted to determine the ratio of total flavonoids in each group of samples to the raw materials, and the ratio is shown in table 1;
2) Total phenol content: the ratio of total phenols in each group of samples to the raw materials is determined by adopting a Fu Lin Fen method, and is shown in table 1;
3) Total triterpene content: determining the ratio of total triterpene in each group of samples to the crude drug by high performance liquid chromatography, see table 1;
TABLE 1
Project | Total flavone, percent | Total phenols, percent | Total triterpene, percent |
Example 1 | 6.31 | 3.89 | 4.12 |
Example 2 | 6.46 | 3.86 | 4.18 |
Example 3 | 6.25 | 3.84 | 4.17 |
Comparative example 1 | 5.97 | 2.06 | 2.15 |
Comparative example 2 | 3.83 | 1.95 | 1.89 |
Comparative example 3 | 5.92 | 3.76 | 4.03 |
Example 4
1) Preparing a compound bacterial liquid:
adding 200g of bacillus subtilis, 100g of bacillus licheniformis, 100g of lactic acid bacteria and 100g of saccharomycetes into 5L of 10% brown sugar water, uniformly stirring, and standing for 12 hours at the temperature of 32-36 ℃ to obtain compound bacteria liquid;
2) Fermentation:
extracting by adopting the same method as in example 1, collecting pure extracting solution and residual materials, washing the residual materials with deionized water for 5 times, draining off water, and drying at 55 ℃ to constant weight to obtain 721g of dried materials; then 721g of bare stems Jin Yaozi and 721g of madder are added, and the mixture is uniformly mixed with the dried material, crushed and sieved by a 60-mesh sieve to obtain a fermentation material; putting the fermentation materials into a fermentation tank, adding 43ml of compound bacteria liquid, adding 119g of corn meal as a carbon source, finally adding 1.1L of deionized water, uniformly stirring, starting fermentation, and filtering and sterilizing after 4d fermentation to obtain a fermentation filtrate;
3) Preparation:
mixing the pure extractive solution obtained by extraction with fermented filtrate obtained by fermentation, concentrating to about 800mL, standing for 24 hr, filtering, adding stevioside 2g and sodium benzoate 3g into the filtrate, heating to dissolve, adding water to adjust total volume to 1000mL, stirring, refrigerating for 24 hr, filtering, bottling, and sterilizing.
Example 5
1) Preparing a compound bacterial liquid:
adding 200g of bacillus subtilis, 100g of bacillus licheniformis, 100g of lactic acid bacteria and 100g of saccharomycetes into 5L of 10% brown sugar water, uniformly stirring, and standing for 12 hours at the temperature of 32-36 ℃ to obtain compound bacteria liquid;
2) Fermentation:
collecting pure extract and residual materials after extraction by the same method as in example 2, cleaning the residual materials with deionized water for 4 times, draining off water, and drying at 50deg.C to constant weight to obtain 732g of dried materials; then 732g of bare stems Jin Yaozi and 732g of madder are added, evenly mixed with the dried material, crushed and sieved by a 60-mesh sieve to obtain a fermentation material; adding the fermentation materials into a fermentation tank, adding 22ml of compound bacteria liquid, adding 110g of corn meal as a carbon source, finally adding 1.1L of deionized water, uniformly stirring, starting fermentation, and filtering and sterilizing after 3d fermentation to obtain a fermentation filtrate;
3) Preparation:
mixing the pure extractive solution obtained by extraction with fermented filtrate obtained by fermentation, concentrating to about 800mL, standing for 24 hr, filtering, adding stevioside 2g and sodium benzoate 3g into the filtrate, heating to dissolve, adding water to adjust total volume to 1000mL, stirring, refrigerating for 24 hr, filtering, bottling, and sterilizing.
Example 6
1) Preparing a compound bacterial liquid:
adding 200g of bacillus subtilis, 100g of bacillus licheniformis, 100g of lactic acid bacteria and 100g of saccharomycetes into 5L of 10% brown sugar water, uniformly stirring, and standing for 12 hours at the temperature of 32-36 ℃ to obtain compound bacteria liquid;
2) Fermentation:
extracting by adopting the same method as in example 3, collecting pure extracting solution and residual materials, cleaning the residual materials with deionized water for 6 times, draining off water, and drying at 60 ℃ to constant weight to obtain 729g of dried materials; adding 729g of bare stems Jin Yaozi and 729g of radix Rubiae, uniformly mixing with the dried material, crushing, and sieving with a 60-mesh sieve to obtain a fermentation material; putting the fermentation materials into a fermentation tank, adding 65.6ml of compound bacteria liquid, adding 131.2g of corn meal as a carbon source, finally adding 1.1L of deionized water, uniformly stirring, starting fermentation, and filtering and sterilizing after fermentation for 5d to obtain a fermentation filtrate;
3) Preparation:
mixing the pure extractive solution obtained by extraction with fermented filtrate obtained by fermentation, concentrating to about 800mL, standing for 24 hr, filtering, adding stevioside 2g and sodium benzoate 3g into the filtrate, heating to dissolve, adding water to adjust total volume to 1000mL, stirring, refrigerating for 24 hr, filtering, bottling, and sterilizing.
Comparative example 4
The comparative example comprises the following steps:
1) Water extraction:
extracting 800g of bare stems Jin Yaozi and 800g of radix Rubiae with water respectively, and mixing to obtain water extracts;
2) Preparation:
extracting by the same method as in example 1, collecting pure extract, mixing the pure extract with water extract, concentrating to about 800mL, standing for 24 hr, filtering, adding stevioside 2g and sodium benzoate 3g into filtrate, heating to dissolve, adding water to adjust total volume to 1000mL, stirring, refrigerating for 24 hr, filtering, bottling, and sterilizing.
Comparative example 5
The comparative example comprises the following steps:
1) Preparing a compound bacterial liquid:
adding 200g of bacillus subtilis, 100g of bacillus licheniformis, 100g of lactic acid bacteria and 100g of saccharomycetes into 5L of 10% brown sugar water, uniformly stirring, and standing for 12 hours at the temperature of 32-36 ℃ to obtain compound bacteria liquid;
2) Fermentation
Extracting by adopting the same method as in the embodiment 1, collecting pure extracting solution and residual materials, cleaning the residual materials by deionized water for 5 times, draining off water, and drying at 55 ℃ until the weight is constant to obtain 722g of dried materials; then adding 1444g of bare stems Jin Yaozi, uniformly mixing with the dried materials, crushing and sieving with a 60-mesh sieve to obtain fermentation materials; putting the fermentation materials into a fermentation tank, adding 43ml of compound bacteria liquid, adding 119g of corn meal as a carbon source, finally adding 1.1L of deionized water, uniformly stirring, starting fermentation, and filtering and sterilizing after 4d fermentation to obtain a fermentation filtrate;
3) Formulations
Mixing the pure extractive solution obtained by extraction with fermented filtrate obtained by fermentation, concentrating to about 800mL, standing for 24 hr, filtering, adding stevioside 2g and sodium benzoate 3g into the filtrate, heating to dissolve, adding water to adjust total volume to 1000mL, stirring, refrigerating for 24 hr, filtering, bottling, and sterilizing.
Comparative example 6
The comparative example comprises the following steps:
1) Preparing a compound bacterial liquid:
adding 200g of bacillus subtilis, 100g of bacillus licheniformis, 100g of lactic acid bacteria and 100g of saccharomycetes into 5L of 10% brown sugar water, uniformly stirring, and standing for 12 hours at the temperature of 32-36 ℃ to obtain compound bacteria liquid;
2) Fermentation
Extracting by adopting the same method as in the embodiment 1, collecting pure extracting solution and residual materials, cleaning the residual materials by deionized water for 5 times, draining off water, and drying at 55 ℃ until the weight is constant to obtain 722g of dried materials; adding 1444g of radix Rubiae, mixing with the dried material, pulverizing, and sieving with 60 mesh sieve to obtain fermented material; putting the fermentation materials into a fermentation tank, adding 43ml of compound bacteria liquid, adding 119g of corn meal as a carbon source, finally adding 1.1L of deionized water, uniformly stirring, starting fermentation, and filtering and sterilizing after 4d fermentation to obtain a fermentation filtrate;
3) Formulations
Mixing the pure extractive solution obtained by extraction with fermented filtrate obtained by fermentation, concentrating to about 800mL, standing for 24 hr, filtering, adding stevioside 2g and sodium benzoate 3g into the filtrate, heating to dissolve, adding water to adjust total volume to 1000mL, stirring, refrigerating for 24 hr, filtering, bottling, and sterilizing.
Experiment 2:
pharmacodynamic experiments:
1) Selecting Wistar rats purchased by Guangzhou southern medical laboratory animal science and technology development limited company, wherein the rats are 7-8 weeks old and have weights of 180-200 g;
2) The Prunella spike oral liquid prepared in examples 4-6 and comparative examples 4-6 was used as a test drug;
3) At the beginning of the experiment, bovine thyroglobulin is firstly adopted to immunize an experimental rat, after modeling is successful, experimental small groups are divided into 7 groups, wherein 1 group is taken as a blank control group to be given with distilled water, 6 groups are respectively given with the tested drugs, the stomach of all groups is irrigated according to the proportion of 1.05ml/kg, the administration is carried out 2 times a day at intervals of 8 hours, and the administration is sacrificed after 12 d. Detecting serum thyroglobulin antibody (TGAb), thyroperoxidase antibody (TPOAb); thyroid tissue was taken, pathological sections were prepared, and morphological examination was performed, and the results are shown in Table 2.
TABLE 2
Claims (3)
1. A preparation method of selfheal oral liquid is characterized in that the selfheal oral liquid is prepared into a medical acceptable oral liquid preparation through extraction, fermentation and liquid preparation, and is characterized in that: the extraction comprises the following steps:
1) Pretreatment:
cleaning Prunellae Spica, oven drying at 50-60deg.C to constant weight, pulverizing, and sieving with 60 mesh sieve to obtain Prunellae Spica powder;
2) Supercritical extraction:
extracting the selfheal powder in a supercritical extraction device, adding entrainer into an entrainer tank, setting the extraction pressure to be 16-18Mpa, the extraction temperature to be 28-30 ℃, the CO2 flow to be 20-25L/h, and the extraction time to be 1-1.5h, and collecting the rest materials and the mixed extract respectively after the extraction is completed;
3) Separating:
placing the above mixed extract in a reduced pressure distillation device, setting pressure at 15mmHg and temperature at 70deg.C, and separating effective substances from Prunellae Spica to obtain pure extractive solution;
the entrainer is as follows: adding 1.2-1.6 parts of N-long-chain acyl alkylene betaine and 1 part of trityl fluorosilane into 4-6 parts of 70% ethanol solution, stirring and dispersing at 400r/min for 10 min.
2. The method for preparing the selfheal oral liquid according to claim 1, which is characterized in that: the fermentation comprises the following steps:
a. washing the residual materials collected after extraction with deionized water for 4-6 times, draining off water, and drying at 50-60 ℃ until the weight is constant to obtain a dry material;
b. respectively taking bare stems Jin Yaozi and madder which have the same weight as the dried materials, uniformly mixing the bare stems Jin Yaozi and the madder with the dried materials, crushing the mixture, and sieving the crushed mixture with a 60-mesh sieve to obtain a fermented material;
c. adding the fermentation materials into a fermentation tank, adding a compound bacterial liquid accounting for 1-3% of the mass of the fermentation materials, adding corn flour accounting for 5-6% of the mass of the fermentation materials as a carbon source, finally adding deionized water with the mass-volume ratio of 2:1 to the fermentation materials, stirring uniformly, starting fermentation, fermenting for 3-5 days, and filtering and sterilizing to obtain a fermentation filtrate;
the preparation method of the compound bacterial liquid comprises the following steps: adding 2 parts of bacillus subtilis, 1 part of bacillus licheniformis, 1 part of lactobacillus and 1 part of saccharomycete into 5 parts of 10% brown sugar water, uniformly stirring, and standing for 12 hours at the temperature of 32-36 ℃ to obtain the compound bacterial liquid.
3. The method for preparing the selfheal oral liquid according to claim 1 or 2, which is characterized in that: the liquid preparation method comprises the following steps:
mixing the pure extractive solution obtained by extraction with the fermented filtrate obtained by fermentation, and making into pharmaceutically acceptable oral liquid preparation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310732445.8A CN116687999A (en) | 2023-06-20 | 2023-06-20 | Preparation method of selfheal oral liquid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310732445.8A CN116687999A (en) | 2023-06-20 | 2023-06-20 | Preparation method of selfheal oral liquid |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116687999A true CN116687999A (en) | 2023-09-05 |
Family
ID=87835522
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310732445.8A Pending CN116687999A (en) | 2023-06-20 | 2023-06-20 | Preparation method of selfheal oral liquid |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116687999A (en) |
-
2023
- 2023-06-20 CN CN202310732445.8A patent/CN116687999A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9950021B2 (en) | Anti-cancer active substance from Antrodia camphorata, method for preparing the same and use thereof | |
CN103223018B (en) | Flos Osmanthi Fragrantis polyphenol extract and its production and use | |
CN108743696B (en) | Nauclea officinalis extract capable of promoting wound healing and application thereof | |
CN114524825B (en) | Bulleyanolide A-T and pharmaceutical composition, preparation method and application thereof | |
CN102526315A (en) | Preparation method of extracts of effective fractions of lychee seeds | |
KR20080074872A (en) | Herb powder extract and preparation method thereof and use method thereof | |
CN101249259B (en) | High content and high activity oral polysaccharide-peptide and preparing method and application of the same | |
CN112472729B (en) | Application of caulis sinomenii in preparing medicine for treating human glioma | |
CN101574398B (en) | Lupulus extractive and preparation method and application thereof | |
Wu et al. | Efficient extraction of caffeic acid derivatives from adventitious roots of Echinacea purpurea | |
CN102319319A (en) | Solanum lyratum extract, and anticancer medicine comprising solanum lyratum extract | |
CN114588184B (en) | Herba Saururi extract, and preparation method and application thereof | |
CN116687999A (en) | Preparation method of selfheal oral liquid | |
KR20190114315A (en) | Method for producing fermentative product of cultured mountain ginseng extract with increased small molecule ginsenoside content and fermentative product of cultured mountain ginseng extract with increased small molecule ginsenoside content produced by the same method | |
CN107556325A (en) | The separation method of Alkaloid monomer in a kind of Diels Stephania Root | |
CN1944384A (en) | Coleus forskohlii extract main component and extracting method | |
CN106386810B (en) | New use of chrysanthemum indicum polysaccharide in promoting synthesis of atractylenolide in rhizoma Atractylodis Macrocephalae | |
CN110522776A (en) | A preparation method and application of anti-tumor effective part of hibiscus hibiscus | |
CN111187309A (en) | Preparation technology and application of four components in Cistanche deserticola | |
CN1775267A (en) | A kind of open arrow extract and its preparation method and application | |
CN106860771B (en) | A kind of preparation method of gastrodia elata refined component and gastrodia elata refined component and application | |
CN115141245B (en) | Cucurbitane-type tetracyclic triterpene compound with anti-mastitis activity extracted from Chinese hemsleya root, and preparation method and application thereof | |
CN101780125B (en) | Medicinal use of acute child against rheumatoid arthritis | |
CN114748490B (en) | Pharmaceutical composition for treating premature ovarian failure, application and preparation method thereof | |
CN115414419B (en) | Composition, preparation method thereof and application thereof in preparation of products with anti-alcohol effect |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |